🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Membranous Nephropathy

Nephrotic Syndrome Study Network NCT01209000n/a44 sites📍 Los Angeles📍 Palo Alto📍 San Francisco University of Michigan · Tests: Kidney Biopsy Atacicept in Multiple Glomerular Diseases NCT06983028Phase 21 site📍 Brisbane Vera Therapeutics, Inc. · Tests: Atacicept Evaluation of Efficacy, Safety, and Tolerability of Povetacicept in Participants With Primary Membranous Nephropathy (pMN) NCT07204275Phase 2, Phase 3117 sites📍 Montgomery📍 Surprise📍 Los Angeles Vertex Pharmaceuticals Incorporated · Tests: Povetacicept, Tacrolimus KOrea Renal Biobank NEtwoRk System TOward NExt-generation Analysis NCT03929887n/a6 sites📍 Chuncheon📍 Daegu📍 Seoul Seoul National University Hospital · Tests: Kidney Biopsy A Phase 1/2 Study of NKX019 in Subjects With Autoimmune Disease (Ntrust-1) NCT06557265Phase 1, Phase 219 sites📍 Little Rock📍 Tustin📍 Gainesville Nkarta, Inc. · Tests: NKX019, Fludarabine, Cyclophosphamide Pharmacokinetics Vancomycin CVVHDF with OXiris Membrane NCT06543940NA1 site📍 Bangkok Mahidol University · Tests: Vancomycin Effect of Kidney Replacement Therapy with Polymethylmethacrylate Membranes on Pruritus-related Quality of Life in Patients Receiving Maintenance Haemodialysis NCT06671535NA1 site📍 Saint Petersburg Saint Petersburg State University, Russia · Tests: Polymethylmethacrylate membrane, polysulfone membranes Evaluation of Integrated Versus Parallel Connection for Renal Replacement Therapy in ECMO Patients NCT06038162NA12 sites📍 Bordeaux📍 Clermont-Ferrand📍 Dijon Hospices Civils de Lyon · Tests: Parallel connection, Integrated connection Accelerated vs. Standard Continuous Renal Replacement Therapy for Patients With Cardiogenic Shock Undergoing Veno-arterial ExtraCorporeal Membrane Oxygenator NCT06696235Phase 42 sites📍 Seoul📍 Seoul Samsung Medical Center · Tests: Early initiation of continuous renal replacement therapy, Standard initiation of continuous renal replacement therapy Raman Spectroscopy Diagnosis of Kidney Diseases NCT06760845n/a1 site📍 Jinan Zunsong Wang · Tests: Imaging Time An Open-Label Phase 2 Study of N-Acetyl-D-Mannosamine (ManNAc) in Subjects With Podocyte Diseases NCT06664814Phase 21 site📍 Bethesda National Human Genome Research Institute (NHGRI) · Tests: ManNAc Anti-Glomerular Basement Membrane Disease NCT07018024n/a1 site📍 Lund Region Skane Study of ALXN1920 in Adult Participants With Primary Membranous Nephropathy (PMN) NCT07157787Phase 240 sites📍 Loma Linda📍 San Diego📍 Minneapolis Alexion Pharmaceuticals, Inc. · Tests: ALXN1920, Placebo A Study to Assess the Effect of Surovatamig in Adult Participants With Antibody-mediated Kidney Disease NCT07571746Phase 227 sites📍 Los Angeles📍 Los Angeles📍 Iowa City AstraZeneca · Tests: Surovatamig Clinical Study of Rituximab Combined With Corticosteroids or Rituximab Monotherapy in the Treatment of Primary Membranous Nephropathy NCT05514015Phase 41 site📍 Guangzhou First Affiliated Hospital, Sun Yat-Sen University · Tests: rituximab combined with corticosteroids, rituximab Combination of Rituximab and Cyclosporine in the Treatment of Primary Membranous Nephropathy NCT07861204Phase 2, Phase 31 site📍 Beijing Peking University First Hospital · Tests: Rituximab combined with cyclosporine, rituximab Rivaroxaban in Idiopathic Membranous Nephropathy NCT07404436Phase 41 site📍 Beijing Beijing Friendship Hospital · Tests: Rivaroxaban 10 MG, Warfarin Sodium Correlation and Clinical Utility of Urinary Biomarker in Membranous Glomerulonephritis NCT05688865n/a1 site📍 Shatin Chinese University of Hong Kong · Tests: urinary markers Study of WAL0921 in Patients With Glomerular Kidney Diseases NCT06466135Phase 250 sites📍 Los Angeles📍 Denver📍 Tamarac Walden Biosciences · Tests: WAL0921, Placebo A Study of SNP-ACTH (1-39) Gel in Patients With Primary Membranous Nephropathy NCT05696613Phase 331 sites📍 Los Angeles📍 San Dimas📍 Tarzana Cerium Pharmaceuticals, Inc. · Tests: SNP-ACTH (1-39) Gel, Rituximab A Phase 2 Study of Budoprutug in Subjects With Primary Membranous Nephropathy NCT07096843Phase 238 sites📍 Denver📍 Orlando📍 Atlanta Climb Bio, Inc. · Tests: budoprutug Comparison of HYDROLINK™ and HeprAN™ mEmbranes in a Per Dialytic Heparin Weaning Strategy in Chronic Hemodialysis Patients NCT05117450NA1 site📍 Reims CHU de Reims · Tests: Decrease per-dialytic heparin therapy A Clinical Study of B007 in the Treatment of Primary Membranous Nephropathy. NCT06470191Phase 2, Phase 321 sites📍 Beijing📍 Beijing📍 Changchun Shanghai Jiaolian Drug Research and Development Co., Ltd · Tests: B007, Cyclosporin Capsules Phase II Randomized, Open-label, Multicenter Clinical Study Evaluating the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of SHR-2173 Injection in Patients With Primary Membranous Nephropathy NCT07289763Phase 21 site📍 Nanjing Guangdong Hengrui Pharmaceutical Co., Ltd · Tests: SHR-2173 injection, SHR-2173 injection, SHR-2173 injection Different Immunosuppressive Treatment in iMN NCT04745728Phase 31 site📍 Beijing Peking Union Medical College Hospital · Tests: Prednisone, Cyclophosphamide, Rituximab Safety and Efficacy of CD19 Chimeric Antigen Receptor T-Cell (CAR-T) in the Treatment of Refractory Membranous Nephropathy NCT07266181Phase 11 site📍 Xi'an The First Affiliated Hospital of Air Force Medical Universi… · Tests: All patients will receive CD19 CAR-T cell therapy on the basis of standard symptomatic and supportive treatment. NEPTUNE Match Study NCT04571658NA16 sites📍 Atlanta📍 Chicago📍 Kansas City University of Michigan · Tests: Communication A Study of Anti-CD19/BCMA Universal CAR-T Cell Therapy RD06-05 in Patients With Autoimmune Diseases. NCT07203404EARLY Phase 11 site📍 Shanghai Nanjing Bioheng Biotech Co., Ltd. · Tests: RD06-05 CART Cell Injection ASF Alport Patient Registry NCT06526741n/a1 site📍 Scottsdale Alport Syndrome Foundation · Tests: Longitudinal data collection Epithelial Dysmetabolism and Renal Fibrosis in ANCA Vasculitis NCT07010250n/a1 site📍 Paris Assistance Publique - Hôpitaux de Paris
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy